Savitz Ryan
- SEC CIK
- 0001992324
In the past year, 4 open-market sale filings worth $14.3M and no purchases.
Current role at each company
- DNTH Dianthus Therapeutics, Inc.EVP, CFO & CBOas of Jul 13, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $14.3M
- 4 filings
- Net
- −$14.3M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Savitz Ryan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 13, 2026 (view filing)5:00 PM ET | Jul 9 | 4 days | Savitz RyanEVP, CFO & CBO | SSale | −31.2K | $101.03 | −$3.16M | −100.0%0 after | 3 lots10b5-1 |
| Apr 10, 2026 (view filing) | Apr 9 | 1 day | Savitz RyanEVP, CFO & CBO | SSale | −8.22K | $89.84 | −$738.8K | −100.0%0 after | 10b5-1 |
| Apr 1, 2026 (view filing) | Mar 31 | 1 day | Savitz RyanEVP, CFO & CBO | SSale | −114.4K | $83.00 | −$9.49M | −100.0%0 after | 8 lots10b5-1 |
| Dec 5, 2025 (view filing) | Dec 4 | 1 day | Savitz RyanCFO & CBO | SSale | −20.0K | $45.18 | −$903.6K | −100.0%0 after | 10b5-1 |
| Sep 11, 2025 (view filing) | Sep 9 | 2 days | Savitz RyanCFO & CBO | SSale | −20.0K | $35.00 | −$700.0K | −100.0%0 after | 10b5-1 |